Congenital cytomegalovirus infection: a presentation of three cases and a literature review

Authors

  • Carlos Eduardo Fonseca-Becerra
  • Gina María Rivera-Tovar

DOI:

https://doi.org/10.18597/rcog.195

Keywords:

Congenital cytomegalovirus, pregnancy, perinatal management, newborn

Abstract

The most frequently occurring perinatal infection is caused by cytomegalovirus (CMV); this infection is the main cause of deafness and compromise during psychomotor development in the fetus and the newborn. Screening, diagnosis and management have not been protocolized in prenatal control. The prognosis for such patients will depend on their suitable management. Three cases are presented with the aim of reviewing prenatal diagnosis and newborn management.

Materials and methods: Three cases of congenital CMV infection are presented; they were diagnosed at the Hernando Moncaleano teaching hospital in Neiva (Huila department) which is a reference centre for Colombia’s south-western region. A search was made of Medline/PudMed, Embase, Lilacs and the Cochrane library databases.

Results: 31 articles were found: 2 evidence-based guidelines, 6 systematic reviews, 2 consensus opinions/guidelines from the Asociación Española de Pediatría, 4 case-control studies, 4 cohort studies, 12 narrative reviews and 1 analytical decisions and costs study.

Conclusion: Routine screening for CMV during prenatal control is not recommended; screening should be done in high-risk pregnant females. Usual screening methods would include specific immunoglobulin IgM (ELISA) and the G (IgG) antibody avidity test. If such test is low, then this would confirm recent infection; the confirmatory test would be PCR for CMV. PCR is used as the screening test in the newborn and the gold standard would be viral culture. Specific immunoglobulin should be used for fetal protection in females suffering gestational infection.

Author Biographies

Carlos Eduardo Fonseca-Becerra

Docente recién nacidos, Universidad Surcolombiana. Neiva, Colombia.

Gina María Rivera-Tovar

Residente Pediatría segundo año, Universidad Surcolombiana. Neiva, Colombia.

References

Feldman DM, Timms D, Borgida AF. Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy. Clin Lab Med 2010;30:709-20.

Tian C, Asad SA, Weitkamp JH. Congenital infections, Part I: Cytomegalovirus, Toxoplasma, Rubella, and Herpes simplex. American Academy of Pediatrics 2010;11;e436-46.

de Vries JJ, Vossen AC, Kroes AC, van der Zeijst BA. Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers. Rev Med Virol 2011;21:54-61.

Cannon MJ, Schmid D, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010;20:202-13.

Nigro G, Adler SP. Cytomegalovirus infections during pregnancy. Curr Opin Obstet Gynecology 2011;23:123-8.

Yinon Y, Farine D, Yudin MH. Screening, Diagnosis, and Management of Cytomegalovirus Infection in Pregnancy. Obstet Gynecol Surv 2010:65:736-43.

Lazzarotto T, Guerra B, Gabrielli L, Lanari M, Landini MP. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect 2011:17:1285-93.

Yinon Y, Farine D, Mark H. Cytomegalovirus Infection in Pregnancy. J Obstet Gynaecol Can 2010;32:348-54.

Baquero-Artigao F y Grupo de estudio de la infección congénita por citomegalovirus de la Sociedad Española de Infectología Pediátrica. Documento sobre el diagnóstico y el tratamiento de la infección congénita por citomegalovirus. Anales de Pediatría 2009;71: 535-47.

Cahill AG, Odibo AO, Stamilio DM, Macones GA. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol 2009;201:466.e1-7.

Seo S, Sook Y, Park J. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test. Korean J Lab Med 2009;29:557-62

Feldman B, Yinon Y, Tepperberg Oikawa M, Yoeli R, Schiff E, et al. Pregestational, periconceptional, and gestational primary maternal cytomegalovirus infection: prenatal diagnosis in 508 pregnancies. Am J Obstet Gynecol 2011;205:342.e1-6.

Gandhi RS, Fernández-Álvarez JR, Rabe H. Management of congenital cytomegalovirus infection: an evidence-based approach. Acta Paediatr 2010;99: 509-15.

Goh W, Sauvage L. CMV Infection in Pregnancy. Donald J Ultrasound Obstet Gynecol 2010;4:43-50.

Nigro G. Maternal-Fetal cytomegalovirus infection: from diagnosis to therapy. J Matern Fetal Neonatal Med 2009;22:169-74.

Al-Hareth Z, Monem F, Megiud N. Is low birth weight a risk indicator for congenital cytomegalovirus infection? J Infect Dev Ctries 2010;4:44-7.

Kim CS. Congenital and perinatal cytomegalovirus infection. Korean J Pediatr 2010;53:14-20.

Baquero-Artigao F. Citomegalovirus congénito: ¿es necesario un cribado serológico durante el embarazo? Enferm Infecc Microbiol Clin 2010;28:363-9.

Adler SP, Nigro G, Pereira L. Recent Advances in the Prevention and Treatment of Congenital Cytomegalovirus Infections. Semin Perinatol 2007; 31:10-8.

Nyholm JL, Schleiss RM. Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health 2010;2:23-35.

Carlier P, Harika N, Bailly R, Vranken G. Laboratory evaluation of the new Access® cytomegalovirus immunoglobulin IgM and IgG assays. J Clin Virol 2010;49:192-7.

Nigro G, Adler SP, La Torre R, Best AM. Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 353:1350-62.

Biron KK. Antiviral drugs for cytomegalovirus diseases. Antiviral Res 2006;71:154-63.

Nigro G, Pentimalli H, Taverna P, Lituania M, de Tejada BM, et al. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008;28:512-7.

Picone O, Vauloup-Fellous C, Cordier AG, Parent Du Châtelet I, Senat MV, Frydman R, et al. A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG 2009;116:818-23.

Kadambari S, Williams EJ, Luckc S, Griffiths P, Sharland M. Evidence based management guidelines for the detection and treatment of congenital CMV. Early Hum Dev 2011;87:723-8.

Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, et al. Saliva polymerasechain- reaction assay for cytomegalovirus screening in newborn. N Engl J Med 2011;364:2111-8.

Wacogne B, Guerrini JC, Mangeat T, Benalia H, Pieralli C, Rouleau A, et al. The Medicalip Project: Toward the screening of the cytomegalovirus. Biomedical engineering 2011;32:66-8.

Lombardi G, Garofoli F, Villani P, Tizzoni M, Angelini M, Cusato M, et al. Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis 2009;28:1465-70.

Baquero-Artigao F. y Grupo de estudio de la infección congénita por citomegalovirus de la Sociedad Española de Infectología Pediátrica. Documento sobre el diagnóstico y el tratamiento de la infección congénita por citomegalovirus. An Pediatr (Barc) 2009;71: 535-47.

Hamprecht K, Maschmannb J, Jahn G, Poets CF, Goelz R. Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol 2008;41:198-205.

How to Cite

1.
Fonseca-Becerra CE, Rivera-Tovar GM. Congenital cytomegalovirus infection: a presentation of three cases and a literature review. Rev. colomb. obstet. ginecol. [Internet]. 2012 Jun. 30 [cited 2024 May 18];63(2):168-74. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/195

Downloads

Download data is not yet available.

Published

2012-06-30
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Some similar items: